PTK2 and hepatocellular carcinoma: Modulation other molecular pathways, such as inhibition of signal transducer and activator of transcription 3/SKP2 axis [36], inhibition of SRC/FAK cue [37], and activation of AMPK et al. [38] have also been involved in the potential anti-HCC effects of statins.